While the pathophysiology of narcolepsy type 1 (NT1) is well characterized by the loss of hypocretin neurons, the pathophysiology of idiopathic hypersomnia (IH) remains unclear, with few evidence-based treatment options (Maski et al., 2021). This evidence concerns the gene HCRT and isolated hemihyperplasia.